Analyzing the Latest from Phase III IPF Clinical Trials
Time: 8:40 am
day: Day Two
Details:
- Understanding the likely next therapies to hit the market
- Accentuating the lessons learned from the trials and what to consider for the future
- Considering how mechanism of action may translate into efficacy
- Understanding the clinical trial endpoints used
